AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

HIV Vaccine

HIV Vaccine and Cure Research Highlights from IAS 2015

"8th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015).
Vancouver, Canada.
Copyright: Marcus Rose/IAS
Image Shows: (WEPL01) Co-chair: Quarraisha Abdool Karim, Centre for the AIDS Programme of Research in South Africa, South Africa"

As the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015) came to a close in Vancouver, Canada, we spoke one last time by Skype with Dr. Carl Dieffenbach, Director of the Division of AIDS at NIH’s National Institute of Allergy and Infectious Diseases (NIAID), to learn about some of the…

NIH’s Dr. Carl Dieffenbach Shares Highlights as IAS 2015 Begins

IAS2015 logo crop2

After the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015) got underway in Vancouver, Canada yesterday, July 20, we spoke by Skype with Dr. Carl Dieffenbach, Director of the Division of AIDS at NIH’s National Institute of Allergy and Infectious Diseases (NIAID). He shared some highlights from the first full…

BULLETIN: HIV Vaccine Awareness Day 2015

nih logo

May 18, 2015 Vaccination has historically been the best method for protecting against and ultimately defeating mankind’s most devastating infectious diseases. Although the path to developing a safe and effective HIV vaccine has so far been difficult, achieving this goal remains key to realizing a durable end to the global HIV/AIDS pandemic. HIV vaccine development…

Statement from Ambassador Deborah L. Birx, M.D., U.S. Global AIDS Coordinator & U.S. Special Representative for Global Health Diplomacy, on HIV Vaccine Awareness Day

pepfar-HVAD-image_square

Editor’s Note: The following statement was released on Friday, May 15 by Ambassador Deborah L. Birx, The United States President’s Emergency Plan for AIDS Relief (PEPFAR) to commemorate today’s observance of HIV Vaccine Awareness Day. May 15, 2015 With no current cure for HIV/AIDS, an HIV vaccine could be a game changer in our effort…

Puerto Rico Makes Important Strides To Support Vaccine Research to Combat HIV

pr

The Obama Administration is a strong partner in helping Puerto Rico to develop the industries that will support its long-term economic growth. One such opportunity is to work through the President’s Task Force on Puerto Rico to identify opportunities can work more closely with partners to ensure that Puerto Rico’s best days are ahead. Earlier…

HIV Vaccine Awareness Day

Dr. Anthony Fauci

Watch NIAID Director Anthony S. Fauci, M.D., discuss current HIV vaccine research approaches. Developing a safe and sufficiently effective HIV vaccine is essential if we are to achieve a timely and durable end to the global HIV/AIDS pandemic. The path to an HIV vaccine has not been—and will not be—an easy one. In the 27…

NIH Names Leadership, Research Units for Restructured HIV/AIDS Clinical Trials Networks

nih logo

The National Institute of Allergy and Infectious Diseases (NIAID) has selected the principal investigators and clinical trials units (CTUs) that will lead and conduct the research of the five restructured HIV/AIDS clinical trials networks through 2021. The new structure is designed to create a broader, more flexible and more collaborative approach to the networks’ research priorities, which…

NIH Scientists Discover How HIV Kills Immune Cells

NIAID

FOR IMMEDIATE RELEASE Wednesday, June 5, 2013 MEDIA AVAILABILITY NIH Scientists Discover How HIV Kills Immune Cells Findings Have Implications for HIV Treatment WHAT: Untreated HIV infection destroys a person’s immune system by killing infection-fighting cells, but precisely when and how HIV wreaks this destruction has been a mystery until now. New research by scientists…